<?xml version="1.0" encoding="UTF-8"?><measure><measureDetails><uuid>40280381-3d61-56a7-013d-694c97db4155</uuid><title>Thrombolytic Therapy</title><shortTitle>STK-4</shortTitle><emeasureid>91</emeasureid><guid>2838875a-07b5-4bf0-be04-c3eb99f53975</guid><version>3</version><status>In Progress</status><nqfid extension="0437" root="2.16.840.1.113883.3.560.1"/><period uuid="6b0d4b72-125d-4ce0-bd80-83da2e6a5e71"><startDate uuid="f07dcd30-ad27-4b00-a282-98ee19c9d750">00000101</startDate><stopDate uuid="d00abb45-e8c6-4118-8b57-112965b70657">00001231</stopDate></period><steward id="1.3.6.1.4.1.33895">Joint Commission</steward><developers><developer id="1.3.6.1.4.1.33895">Joint Commission</developer></developers><endorsement id="2.16.840.1.113883.3.560">National Quality Forum</endorsement><description>Acute ischemic stroke patients who arrive at this hospital within 2 hours of time last known well and for whom IV t-PA was initiated at this hospital within 3 hours of time last known well.</description><copyright>Measure specifications are in the Public Domain.&#13;
&#13;
LOINC(R) is a registered trademark of the Regenstrief Institute.&#13;
&#13;
This material contains SNOMED Clinical Terms (R) (SNOMED CT(c)) copyright 2004-2010 International Health Terminology Standards Development Organization. All rights reserved.</copyright><disclaimer>None</disclaimer><scoring id="PROPOR">Proportion</scoring><types><type id="PROCESS">Process</type></types><stratification>None</stratification><riskAdjustment>None</riskAdjustment><aggregation>None</aggregation><rationale>The administration of thrombolytic agents to carefully screened, eligible patients with acute ischemic stroke has been shown to be beneficial in several clinical trials. These included two positive randomized controlled trials in the United States: The National Institute of Neurological Disorders and Stroke (NINDS) Studies, Part I and Part II. Based on the results of these studies, the Food and Drug Administration approved the use of intravenous recombinant tissue plasminogen activator (IV r-TPA or t-PA) for the treatment of acute ischemic stroke when given within 3 hours of stroke symptom onset. A large meta-analysis controlling for factors associated with stroke outcome confirmed the benefit of IV t-PA in patients treated within 3 hours of symptom onset. While controversy still exists among some specialists, the major society practice guidelines developed in the United States all recommend the use of IV t-PA for eligible patients. Physicians with experience and skill in stroke management and the interpretation of CT scans should supervise treatment.</rationale><recommendations>The administration of thrombolytic agents to carefully screened, eligible patients with acute ischemic stroke has been shown to be beneficial in several clinical trials. Intravenous recombinant tissue plasminogen activator (IV r-TPA or t-PA) should be used for the treatment of acute ischemic stroke when given within 3 hours of stroke symptom onset.</recommendations><improvementNotations>An increase in the rate</improvementNotations><references><reference>Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks E. Guidelines for the Early Management of Adults with Ischemic Stroke: A Guideline From the American Heart Association/American Stroke, Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke. 2007;38:1655-1711.</reference><reference>Adams H, Adams R, Del Zoppo G, Goldstein LB. American Heart Association/American Stroke Association Guidelines Update A Scientific Statement From the Stroke Council of the Guidelines for the Early Management of Patients With Ischemic Stroke: 2005, Stroke.2005;36;916-923.</reference><reference>Antithrombotic and Thrombolytic Therapy for Ischemic Stroke The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Gregory W. Albers, MD, Chair; Pierre Amarenco, MD; J. Donald Easton, MD; Ralph L. Sacco, MD; and Philip Teal, MD (CHEST 2004; 126:483S?512S).</reference><reference>del Zoppo GJ, Saver JL, Jauch EC, Adams HP. Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator: A Science Advisory From the American Heart Association/ American Stroke Association. Stroke. 2009;40:2945-2948.</reference><reference>Diagnosis and Initial Treatment of Ischemic Stroke, Institute for Clinical Systems Improvement (ICSI), 2001.</reference><reference>Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Gidetti D, et. al. Thrombolysis with Alteplase 3 to 4.5 hours after acute ischemic stroke. The European Cooperative Acute Stroke Study (ECASS) Investigators. NEJM. 2008;359(13):1317-29.</reference><reference>Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-1025.</reference><reference>Management of Patients with Stroke. Assessment, investigation, immediate management and secondary prevention, Scottish Intercollegiate Guidelines Network, 1997.</reference><reference>Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, Broderick JP, Levine SR, Frankel MP, Horowitz SH, Haley EC, Lewandowski CA, Kwiatkowski TP. Early stroke treatment associated with better outcome The NINDS rt-PA Stroke Study. Neurology 2000;55: 1649-1655.</reference><reference>Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention. Stroke. Vol. 37, 2006:577.</reference><reference>STROKE the First Hours Guidelines for Acute Treatment, National Stroke Association, 2000.</reference><reference>The ATLANTIS, ECASS, and NINDS rt-PA Study Group Investigators. Association of Outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke Trials. Lancet 2004;363:768-774.</reference><reference>The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. New England Journal of Medicine 1995;333:1581-1587.</reference></references><definitions>None</definitions><guidance>The unit of measurement for this measure is an inpatient episode of care. Each distinct hospitalization should be reported, regardless of whether the same patient is admitted for inpatient care more than once during the measurement period. In addition, the eMeasure logic intends to represent events within or surrounding a single occurrence of an inpatient hospitalization.&#13;
&#13;
The facility location arrival datetime and facility location departure datetime are coupled with the emergency department visit value set. They intend to represent arrival date/time at the emergency department and the discharge date/time from the emergency department, respectively.&#13;
&#13;
The baseline state data value set and its associated stop date/time intend to capture the date and time prior to hospital arrival at which it was witnessed or reported that the patient was last known to be without the signs and symptoms of the current stroke or at his or her baseline state of health.&#13;
&#13;
The ?Non-elective admissions? value set intends to capture all non-scheduled hospitalizations. This value set is a subset of the ?Inpatient encounter? value set, excluding concepts that specifically refer to elective hospital admissions. Non-elective admissions include emergency, urgent and unplanned admissions, including patients admitted for observation.</guidance><transmissionFormat>None</transmissionFormat><initialPatientPopDescription>Patients admitted to the hospital for inpatient acute care with a Principal Diagnosis Code for ischemic or hemorrhagic stroke with hospital stays &lt;= 120 days during the measurement period for patients age 18 and older at the time of hospital admission.</initialPatientPopDescription><denominatorDescription>Acute ischemic stroke patients whose time of arrival is within 2 hours (less than or equal to 120 minutes) of time last known well.</denominatorDescription><denominatorExclusionsDescription>Patients admitted for Elective Carotid Intervention, or&#13;
Patients with a documented Reason For Not Initiating IV Thrombolytic</denominatorExclusionsDescription><numeratorDescription>Acute ischemic stroke patients for whom IV thrombolytic therapy was initiated at this hospital within 3 hours (less than or equal to 180 minutes) of time last known well.</numeratorDescription><numeratorExclusionsDescription>Not Applicable</numeratorExclusionsDescription><denominatorExceptionsDescription>None</denominatorExceptionsDescription><measurePopulationDescription>Not Applicable</measurePopulationDescription><measureObservationsDescription>Not Applicable</measureObservationsDescription><supplementalData>For every patient evaluated by this measure also identify payer, race, ethnicity and sex.</supplementalData><qualityMeasureSet uuid="43961ad1-192f-42e5-848c-f3f93147fc60">eMeasure Stroke (eSTK)</qualityMeasureSet>
<finalizedDate value="201402111146-0600"/>
</measureDetails><supplementalDataElements><elementRef id="40280381-3d61-56a7-013d-694c97f34156" name="ONC Administrative Sex"/><elementRef id="40280381-3d61-56a7-013d-694c97f34157" name="Race"/><elementRef id="40280381-3d61-56a7-013d-694c97f34158" name="Ethnicity"/><elementRef id="40280381-3d61-56a7-013d-694c97f34159" name="Payer"/></supplementalDataElements><measureGrouping><group sequence="1"><clause displayName="Initial Patient Population 1" type="initialPatientPopulation" uuid="D2073B78-58FA-4C32-ADC0-7F78FAD1B41F"><logicalOp displayName="AND" type="and"><relationalOp displayName="&gt;= 18 years Starts Before Start Of" operatorType="Greater Than or Equal To" quantity="18" type="SBS" unit="years"><elementRef displayName="birth date : Patient Characteristic Birthdate" id="40280381-3d61-56a7-013d-694c97f44167" type="qdm"/><elementRef displayName="Occurrence A of Non-Elective Inpatient Encounter : Encounter, Performed" id="40280381-3d61-56a7-013d-7f4a234a5668" type="qdm"/></relationalOp><elementRef displayName="Occurrence A of Non-Elective Inpatient Encounter : Encounter, Performed" id="40280381-3d61-56a7-013d-7f4a234a5668" type="qdm"><attribute comparisonValue="120" mode="Less Than or Equal To" name="length of stay" unit="days"/></elementRef><relationalOp displayName="During" type="DURING"><elementRef displayName="Occurrence A of Non-Elective Inpatient Encounter : Encounter, Performed" id="40280381-3d61-56a7-013d-7f4a234a5668" type="qdm"><attribute mode="Check if Present" name="discharge datetime"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013d-694c97f44162" type="qdm"/></relationalOp><relationalOp displayName="Starts During" type="SDU"><logicalOp displayName="OR" type="or"><elementRef displayName="Ischemic Stroke : Diagnosis, Active" id="40280381-3d61-56a7-013d-694c97f4415b" type="qdm"><attribute mode="Value Set" name="ordinality" qdmUUID="40280381-3d61-56a7-013d-694c97f44163"/></elementRef><elementRef displayName="Hemorrhagic Stroke : Diagnosis, Active" id="40280381-3d61-56a7-013d-694c97f4415c" type="qdm"><attribute mode="Value Set" name="ordinality" qdmUUID="40280381-3d61-56a7-013d-694c97f44163"/></elementRef></logicalOp><elementRef displayName="Occurrence A of Non-Elective Inpatient Encounter : Encounter, Performed" id="40280381-3d61-56a7-013d-7f4a234a5668" type="qdm"/></relationalOp></logicalOp></clause><clause displayName="Denominator 1" type="denominator" uuid="694B216E-E2B1-4870-A844-BD07428191AD"><logicalOp displayName="AND" type="and"><relationalOp displayName="Starts During" type="SDU"><elementRef displayName="Ischemic Stroke : Diagnosis, Active" id="40280381-3d61-56a7-013d-694c97f4415b" type="qdm"><attribute mode="Value Set" name="ordinality" qdmUUID="40280381-3d61-56a7-013d-694c97f44163"/></elementRef><elementRef displayName="Occurrence A of Non-Elective Inpatient Encounter : Encounter, Performed" id="40280381-3d61-56a7-013d-7f4a234a5668" type="qdm"/></relationalOp><relationalOp displayName="&lt;= 1 hours Starts After End Of" operatorType="Less Than or Equal To" quantity="1" type="SAE" unit="hours"><elementRef displayName="Occurrence A of Non-Elective Inpatient Encounter : Encounter, Performed" id="40280381-3d61-56a7-013d-7f4a234a5668" type="qdm"><attribute mode="Check if Present" name="admission datetime"/></elementRef><elementRef displayName="Occurrence A of Emergency Department Visit : Encounter, Performed" id="40280381-3d61-56a7-013d-694c97f54174" type="qdm"/></relationalOp><relationalOp displayName="&lt;= 120 minutes Starts Before Start Of" operatorType="Less Than or Equal To" quantity="120" type="SBS" unit="minutes"><logicalOp displayName="OR" type="or"><elementRef displayName="Occurrence A of Neurologic Symptoms of Stroke : Symptom, Active" id="40280381-3d61-56a7-013d-694c97f54172" type="qdm"><attribute mode="Check if Present" name="start datetime"/></elementRef><elementRef displayName="Occurrence A of Baseline State : Symptom, Active" id="40280381-3d61-56a7-013d-694c97f54171" type="qdm"><attribute mode="Check if Present" name="stop datetime"/></elementRef></logicalOp><elementRef displayName="Occurrence A of Emergency Department Visit : Encounter, Performed" id="40280381-3d61-56a7-013d-694c97f54174" type="qdm"><attribute mode="Check if Present" name="facility location arrival datetime"/></elementRef></relationalOp></logicalOp></clause><clause displayName="Denominator Exclusions 1" type="denominatorExclusions" uuid="3E8C5BDC-B519-4BB3-BA3C-3CAE32FC01ED"><logicalOp displayName="AND" type="and"><logicalOp displayName="OR" type="or"><relationalOp displayName="&lt;= 180 minutes Starts After Start Of" operatorType="Less Than or Equal To" quantity="180" type="SAS" unit="minutes"><logicalOp displayName="OR" type="or"><elementRef displayName="Thrombolytic (t-PA) Therapy : Medication, Order" id="40280381-3d61-56a7-013d-694c97f4416d" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013d-694c97f44166"/></elementRef><elementRef displayName="Thrombolytic (t-PA) Therapy : Medication, Order" id="40280381-3d61-56a7-013d-694c97f4416d" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013d-694c97f44165"/></elementRef><elementRef displayName="Thrombolytic (t-PA) Therapy : Medication, Administered" id="40280381-3d61-56a7-013d-694c97f44160" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013d-694c97f44166"/></elementRef><elementRef displayName="Thrombolytic (t-PA) Therapy : Medication, Administered" id="40280381-3d61-56a7-013d-694c97f44160" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013d-694c97f44165"/></elementRef></logicalOp><elementRef displayName="Occurrence A of Baseline State : Symptom, Active" id="40280381-3d61-56a7-013d-694c97f54171" type="qdm"><attribute mode="Check if Present" name="stop datetime"/></elementRef></relationalOp><relationalOp displayName="&lt;= 180 minutes Starts After Start Of" operatorType="Less Than or Equal To" quantity="180" type="SAS" unit="minutes"><logicalOp displayName="OR" type="or"><elementRef displayName="Thrombolytic (t-PA) Therapy : Medication, Order" id="40280381-3d61-56a7-013d-694c97f4416d" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013d-694c97f44166"/></elementRef><elementRef displayName="Thrombolytic (t-PA) Therapy : Medication, Order" id="40280381-3d61-56a7-013d-694c97f4416d" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013d-694c97f44165"/></elementRef><elementRef displayName="Thrombolytic (t-PA) Therapy : Medication, Administered" id="40280381-3d61-56a7-013d-694c97f44160" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013d-694c97f44166"/></elementRef><elementRef displayName="Thrombolytic (t-PA) Therapy : Medication, Administered" id="40280381-3d61-56a7-013d-694c97f44160" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013d-694c97f44165"/></elementRef></logicalOp><elementRef displayName="Occurrence A of Neurologic Symptoms of Stroke : Symptom, Active" id="40280381-3d61-56a7-013d-694c97f54172" type="qdm"><attribute mode="Check if Present" name="start datetime"/></elementRef></relationalOp><relationalOp displayName="&lt;= 180 minutes Starts After Start Of" operatorType="Less Than or Equal To" quantity="180" type="SAS" unit="minutes"><elementRef displayName="National Institute of Health Stroke Scale : Risk Category Assessment" id="40280381-3d61-56a7-013d-694c97f44169" type="qdm"><attribute comparisonValue="0" mode="Equal To" name="result" unit=""/></elementRef><logicalOp displayName="OR" type="or"><elementRef displayName="Occurrence A of Neurologic Symptoms of Stroke : Symptom, Active" id="40280381-3d61-56a7-013d-694c97f54172" type="qdm"><attribute mode="Check if Present" name="start datetime"/></elementRef><elementRef displayName="Occurrence A of Baseline State : Symptom, Active" id="40280381-3d61-56a7-013d-694c97f54171" type="qdm"><attribute mode="Check if Present" name="stop datetime"/></elementRef></logicalOp></relationalOp><relationalOp displayName="&lt;= 2 days Starts Before Start Of" operatorType="Less Than or Equal To" quantity="2" type="SBS" unit="days"><elementRef displayName="Thrombolytic (t-PA) Therapy : Medication, Administered" id="40280381-3d61-56a7-013d-694c97f44160" type="qdm"/><elementRef displayName="Occurrence A of Emergency Department Visit : Encounter, Performed" id="40280381-3d61-56a7-013d-694c97f54174" type="qdm"/></relationalOp></logicalOp></logicalOp></clause><clause displayName="Numerator 1" type="numerator" uuid="0EEE3BB4-30E4-4DE2-9FC6-4E631F03894C"><logicalOp displayName="AND" type="and"><logicalOp displayName="OR" type="or"><relationalOp displayName="&lt;= 180 minutes Starts After Start Of" operatorType="Less Than or Equal To" quantity="180" type="SAS" unit="minutes"><elementRef displayName="Thrombolytic (t-PA) Therapy : Medication, Administered" id="40280381-3d61-56a7-013d-694c97f44160" type="qdm"/><elementRef displayName="Occurrence A of Baseline State : Symptom, Active" id="40280381-3d61-56a7-013d-694c97f54171" type="qdm"><attribute mode="Check if Present" name="stop datetime"/></elementRef></relationalOp><relationalOp displayName="&lt;= 180 minutes Starts After Start Of" operatorType="Less Than or Equal To" quantity="180" type="SAS" unit="minutes"><elementRef displayName="Thrombolytic (t-PA) Therapy : Medication, Administered" id="40280381-3d61-56a7-013d-694c97f44160" type="qdm"/><elementRef displayName="Occurrence A of Neurologic Symptoms of Stroke : Symptom, Active" id="40280381-3d61-56a7-013d-694c97f54172" type="qdm"><attribute mode="Check if Present" name="start datetime"/></elementRef></relationalOp></logicalOp></logicalOp></clause></group></measureGrouping><elementLookUp><qdm codeSystemName="National Library of Medicine" datatype="Patient Characteristic Sex" id="40280381-3d61-56a7-013d-694c97f34156" name="ONC Administrative Sex" oid="2.16.840.1.113762.1.4.1" suppDataElement="true" taxonomy="Administrative Sex" uuid="40280381-3d61-56a7-013d-694c97f34156" version="1"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Race" id="40280381-3d61-56a7-013d-694c97f34157" name="Race" oid="2.16.840.1.114222.4.11.836" suppDataElement="true" taxonomy="CDC" uuid="40280381-3d61-56a7-013d-694c97f34157" version="1"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Ethnicity" id="40280381-3d61-56a7-013d-694c97f34158" name="Ethnicity" oid="2.16.840.1.114222.4.11.837" suppDataElement="true" taxonomy="CDC" uuid="40280381-3d61-56a7-013d-694c97f34158" version="1"/><qdm codeSystemName="PHDSC" datatype="Patient Characteristic Payer" id="40280381-3d61-56a7-013d-694c97f34159" name="Payer" oid="2.16.840.1.114222.4.11.3591" suppDataElement="true" taxonomy="Source of Payment Typology" uuid="40280381-3d61-56a7-013d-694c97f34159" version="1"/><qdm codeSystemName="Joint Commission" datatype="Diagnosis, Active" id="40280381-3d61-56a7-013d-694c97f4415b" name="Ischemic Stroke" oid="2.16.840.1.113883.3.117.1.7.1.247" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013d-694c97f4415b" version="1"/><qdm codeSystemName="Joint Commission" datatype="Diagnosis, Active" id="40280381-3d61-56a7-013d-694c97f4415c" name="Hemorrhagic Stroke" oid="2.16.840.1.113883.3.117.1.7.1.212" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013d-694c97f4415c" version="1"/><qdm codeSystemName="Joint Commission" datatype="Medication, Administered" id="40280381-3d61-56a7-013d-694c97f44160" name="Thrombolytic (t-PA) Therapy" oid="2.16.840.1.113883.3.117.1.7.1.226" suppDataElement="false" taxonomy="RxNorm" uuid="40280381-3d61-56a7-013d-694c97f44160" version="1"/><qdm codeSystemName="National Quality Forum" datatype="Timing Element" id="40280381-3d61-56a7-013d-694c97f44162" name="Measurement Period" oid="2.16.840.1.113883.3.67.1.101.1.53" suppDataElement="false" taxonomy="NQF" uuid="40280381-3d61-56a7-013d-694c97f44162" version="1"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3d61-56a7-013d-694c97f44163" name="Principal Diagnosis" oid="2.16.840.1.113883.3.117.2.7.1.14" suppDataElement="false" taxonomy="SNOMED-CT" uuid="40280381-3d61-56a7-013d-694c97f44163" version="1"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3d61-56a7-013d-694c97f44165" name="Patient Refusal" oid="2.16.840.1.113883.3.117.1.7.1.93" suppDataElement="false" taxonomy="SNOMED-CT" uuid="40280381-3d61-56a7-013d-694c97f44165" version="1"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3d61-56a7-013d-694c97f44166" name="Medical Reason" oid="2.16.840.1.113883.3.117.1.7.1.473" suppDataElement="false" taxonomy="SNOMED-CT" uuid="40280381-3d61-56a7-013d-694c97f44166" version="1"/><qdm codeSystemName="National Quality Forum" datatype="Patient Characteristic Birthdate" id="40280381-3d61-56a7-013d-694c97f44167" name="birth date" oid="2.16.840.1.113883.3.560.100.4" suppDataElement="false" taxonomy="LOINC" uuid="40280381-3d61-56a7-013d-694c97f44167" version="1"/><qdm codeSystemName="Joint Commission" datatype="Risk Category Assessment" id="40280381-3d61-56a7-013d-694c97f44169" name="National Institute of Health Stroke Scale" oid="2.16.840.1.113883.3.117.1.7.1.269" suppDataElement="false" taxonomy="LOINC" uuid="40280381-3d61-56a7-013d-694c97f44169" version="1"/><qdm codeSystemName="Joint Commission" datatype="Medication, Order" id="40280381-3d61-56a7-013d-694c97f4416d" name="Thrombolytic (t-PA) Therapy" oid="2.16.840.1.113883.3.117.1.7.1.226" suppDataElement="false" taxonomy="RxNorm" uuid="40280381-3d61-56a7-013d-694c97f4416d" version="1"/><qdm codeSystemName="Joint Commission" datatype="Symptom, Active" id="40280381-3d61-56a7-013d-694c97f54171" instance="Occurrence A" name="Baseline State" oid="2.16.840.1.113883.3.117.1.7.1.417" suppDataElement="false" taxonomy="SNOMED-CT" uuid="40280381-3d61-56a7-013d-694c97f54171" version="1"/><qdm codeSystemName="Joint Commission" datatype="Symptom, Active" id="40280381-3d61-56a7-013d-694c97f54172" instance="Occurrence A" name="Neurologic Symptoms of Stroke" oid="2.16.840.1.113883.3.117.1.7.1.399" suppDataElement="false" taxonomy="SNOMED-CT" uuid="40280381-3d61-56a7-013d-694c97f54172" version="1"/><qdm codeSystemName="Lantana" datatype="Encounter, Performed" id="40280381-3d61-56a7-013d-694c97f54174" instance="Occurrence A" name="Emergency Department Visit" oid="2.16.840.1.113883.3.117.1.7.1.292" suppDataElement="false" taxonomy="SNOMED-CT" uuid="40280381-3d61-56a7-013d-694c97f54174" version="1"/><qdm codeSystemName="Joint Commission" datatype="Encounter, Performed" id="40280381-3d61-56a7-013d-7f4a234a5668" instance="Occurrence A" name="Non-Elective Inpatient Encounter" oid="2.16.840.1.113883.3.117.1.7.1.424" suppDataElement="false" taxonomy="SNOMED-CT" uuid="40280381-3d61-56a7-013d-7f4a234a5668" version="1"/></elementLookUp><strata displayName="Stratification"><clause displayName="Stratum 1" type="stratum" uuid="40280381-3d61-56a7-013d-694ce08f41d9"><logicalOp displayName="AND" type="and"/></clause></strata></measure>
